Drug Trial Radar · NCT04105010
Assessing An Oral Janus Kinase Inhibitor, AZD4205 as Monotherapy in Patients Who Have PTCL (JACKPOT8)
Last checked: Nov 19, 2026Latest source record: Apr 4, 2025 (this record)Source: ClinicalTrials.govMethods & limitations
Status
Completed
Enrollment
171
Actual
Start
Sep 10, 2019
Primary completion
Oct 12, 2023
Study completion Feb 22, 2024
Sponsor
- Lead sponsor
- Dizal PharmaceuticalsIndustry
- Sponsor type
- Industry
- First posted
- Sep 26, 2019
Design
- Study type
- Interventional
- Phase
- Phase 1 / Phase 2
- Allocation
- Non randomized
- Model
- Sequential
- Masking
- None
- Primary purpose
- Treatment
- FDA-regulated drug
- Yes
- Who can join
- All sexes, from 18 years
- Healthy volunteers
- No
Summary
As written by the sponsor on the registry.
This is a multinational, non-randomized, open-label, Phase 1/2 clinical study to evaluate the safety, tolerability and anti-tumor efficacy of AZD4205 as monotherapy in patients with peripheral T cell lymphoma (PTCL), who have relapsed from or are refractory/intolerant to standard systemic treatment. Phase 1 part: Around 20\~40 patients will be subsequently enrolled into 2 different dose ascending cohorts. Additional 10\~20 patients may be enrolled to further explore a selected dose defined by dose escalation cohorts. Phase 2 part: After the recommended phase 2 dose (RP2D) is defined, a phase 2 single-arm open-label pivotal study will be conducted to assess anti-tumor efficacy and safety of AZD4205 at RP2D in patients with refractory or relapsed PTCL.
Conditions
- Relapsed or Refractory Peripheral T Cell Lymphoma
Interventions
golidocitinibDrug
golidocitinib will be administered orally as capsules. golidocitinib treatment will be continued until disease progression or intolerant adverse reactions
Primary outcomes
What the sponsor says the trial is designed to measure.
- Part B: CT-based Objective Response Rate (ORR) by Independent Review Committee (IRC)Time frame: Up to approximately 3 years
Locations
50 sites in 4 countries. Site status is shown where the registry gives one.
Yale Cancer Center
New Haven, Connecticut
Winship Cancer Institute
Atlanta, Georgia
Washington University School of Medicine
St Louis, Missouri
The University of Texas MD Anderson Cancer Center
Houston, Texas
Epworth Hospital
East Melbourne, Australia
St Vincent's Hospital Melbourne
Fitzroy, Australia
Royal Hobart Hospital
Hobart, Australia
St George Hospital
Kogarah, Australia
Royal Perth Hospital
Perth, Australia
Westmead Hospital
Westmead, Australia
Beijing Cancer Hospital
Beijing, China
Beijing Friendship Hospital, Capital Medical University
Beijing, China
Beijing Hospital
Beijing, China
Peking University Third Hospital
Beijing, China
The First Hospital of Jilin University
Changchun, China
Hunan Cancer Hospital
Changsha, China
Xiangya Hospital Central South University
Changsha, China
Sichuan University - West China Hospital
Chengdu, China
Chongqing University Cancer Hospital
Chongqing, China
The Second Hospital of Dalian Medical University
Dalian, China
Guangdong Provincial People's Hospital
Guangzhou, China
NanFang Hospital of Southern Medical University
Guangzhou, China
Sun Yat-sen University Cancer Center
Guangzhou, China
Hainan General Hospital
Haikou, China
The First Affiliated Hospital, Zhejiang University School of Medicine
Hangzhou, China
Zhejiang Cancer Hospital
Hangzhou, China
Anhui Provincial Cancer Hospital
Hefei, China
The Second Hospital of Anhui Medical University
Hefei, China
Shandong Cancer Hospital
Jinan, China
The First Hospital of Lanzhou University
Lanzhou, China
Linyi Cancer Hospital
Linyi, China
Jiangxi Province Cancer Hospital
Nanchang, China
The First Affiliated Hospital of Nanchang University
Nanchang, China
Jiangsu Cancer Hospital
Nanjing, China
Fudan University Shanghai Cancer Center
Shanghai, China
Ruijin Hospital Shanghai Jiaotong University School of Medicine
Shanghai, China
The First Affiliated Hospital of Soochow University
Suzhou, China
Tianjin Medical University Cancer Institute and Hospital
Tianjin, China
Union Hospital Tongji Medical College Huazhong University of Science and Technology
Wuhan, China
The First Affiliated Hospital of Xiamen University
Xiamen, China
Showing 40 of 50 sites, US sites first. The full list is on the registry record.
Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.